Pond Technologies

Pond Technologies produces microalgal biomass using carbon dioxide emissions from industrial plants. The resulting algae is used in nutraceuticals, superfoods, animal feeds, biofoams, biomaterials, and other algae-derived products. Additionally, Pond focuses on the terrestrial plant industry.

Kevin Andrade

COO, Operations

Steven Martin

Co-Founder, CEO and Board Member

Grant Smith

CEO and Board Member

1 past transactions

Regenurex Health

Acquisition in 2018
Regenurex Health Corporation, based in Surrey, Canada, operates a 10,000 square foot algae production facility in Agassiz, British Columbia. The company specializes in the cultivation and extraction of astaxanthin, a powerful antioxidant and anti-inflammatory nutraceutical derived from algae. Regenurex employs a proprietary natural extraction process that ensures the preservation of the beneficial properties of the whole algae, resulting in a unique and high-quality product. Their sustainable and environmentally friendly practices cater to the nutraceutical, cosmetic, and pharmaceutical industries, focusing on health-enhancing nutritional supplements that combat oxidative stress and inflammation, which are linked to aging and various health conditions. As of January 30, 2019, Regenurex operates as a subsidiary of Pond Naturals Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.